A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: A novel pharmacogenetic approach
Kelan L H Thomas, Vicki L. Ellingrod, Jeffrey R. Bishop, Michael J. Keiser
Dive into the research topics of 'A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: A novel pharmacogenetic approach'. Together they form a unique fingerprint.